Miscellaneous approaches and considerations: TLR agonists and other inflammatory agents, anti-chemokine agents, infectious agents, tumor stroma targeting, age and sex effects, and miscellaneous small molecules

Biochemistry, Genetics and Molecular Biology

• Age 50%
• Agonist 100%
• Cancer Immunotherapy 50%
• Clinical Trial 50%
• Development 50%
• Infectious Agent 50%
• Mycobacterium Bovis BCG 50%
• Small Molecule 50%